These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8395698

  • 1. Endocoids in depression: do antidepressants alter endocoids that affect the serotonergic system?
    Leonard BE.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jul; 17(4):505-14. PubMed ID: 8395698
    [Abstract] [Full Text] [Related]

  • 2. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.
    Owens MJ, Nemeroff CB.
    Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830
    [Abstract] [Full Text] [Related]

  • 3. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M, Tsukamoto T.
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [Abstract] [Full Text] [Related]

  • 4. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD, Bakish D, Ravindran A, Chudzik J, Cavazzoni P, Lapierre YD.
    Psychiatry Res; 1997 Feb 07; 66(2-3):73-85. PubMed ID: 9075272
    [Abstract] [Full Text] [Related]

  • 5. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ, Nemeroff CB.
    Depress Anxiety; 2000 Feb 07; 12 Suppl 1():2-19. PubMed ID: 11098410
    [Abstract] [Full Text] [Related]

  • 6. Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter.
    Spurlock G, Buckland P, O'Donovan M, McGuffin P.
    Neuropharmacology; 1994 Feb 07; 33(3-4):433-40. PubMed ID: 7984281
    [Abstract] [Full Text] [Related]

  • 7. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies.
    Pandey GN.
    Ann N Y Acad Sci; 1997 Dec 29; 836():182-200. PubMed ID: 9616799
    [Abstract] [Full Text] [Related]

  • 8. Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.
    Roggenbach J, Müller-Oerlinghausen B, Franke L, Uebelhack R, Blank S, Ahrens B.
    J Neural Transm (Vienna); 2007 Dec 29; 114(4):479-87. PubMed ID: 16988795
    [Abstract] [Full Text] [Related]

  • 9. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.
    Köhler S, Cierpinsky K, Kronenberg G, Adli M.
    J Psychopharmacol; 2016 Jan 29; 30(1):13-22. PubMed ID: 26464458
    [Abstract] [Full Text] [Related]

  • 10. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan KR.
    Am J Psychiatry; 1994 Nov 29; 151(11):1623-5. PubMed ID: 7943450
    [Abstract] [Full Text] [Related]

  • 11. LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug.
    Wong DT, Robertson DW, Bymaster FP, Krushinski JH, Reid LR.
    Life Sci; 1988 Nov 29; 43(24):2049-57. PubMed ID: 2850421
    [Abstract] [Full Text] [Related]

  • 12. Increases in platelet 5HT uptake rates following treatment with "uptake inhibiting" drugs.
    Healy D, O'Halloran A, Leonard BE.
    Int Clin Psychopharmacol; 1986 Oct 29; 1(4):332-9. PubMed ID: 3559157
    [Abstract] [Full Text] [Related]

  • 13. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK, Post RM.
    Adv Biochem Psychopharmacol; 1974 Oct 29; 11(0):341-55. PubMed ID: 4276863
    [No Abstract] [Full Text] [Related]

  • 14. Antidepressant treatment and limbic serotonergic mechanisms regulating rat locomotor activity.
    Plaznik A, Stefanski R, Palejko W, Bidzinski A, Kostowski W, Jessa M, Nazar M.
    Pharmacol Biochem Behav; 1994 Jun 29; 48(2):315-25. PubMed ID: 8090797
    [Abstract] [Full Text] [Related]

  • 15. Effects of repeated trazodone administrations on serotonergic neurotransmission: biochemical studies.
    Gandolfi O, Roncada P, Dall'Olio R.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 Jun 29; 13(6):941-52. PubMed ID: 2554363
    [Abstract] [Full Text] [Related]

  • 16. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.
    Morilak DA, Frazer A.
    Int J Neuropsychopharmacol; 2004 Jun 29; 7(2):193-218. PubMed ID: 15003145
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological effects of serotonin reuptake inhibitors.
    Leonard BE.
    J Clin Psychiatry; 1988 Aug 29; 49 Suppl():12-7. PubMed ID: 3045106
    [Abstract] [Full Text] [Related]

  • 18. The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients.
    Kelly JP, Nicolau G, Redmond A, Leonard BE, Noble J, Sverdlov L, Molinar R, Kastin AJ, Ehrensing RH, Feighner JP.
    J Affect Disord; 1999 Oct 29; 55(2-3):231-5. PubMed ID: 10628893
    [Abstract] [Full Text] [Related]

  • 19. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO, Kuteeva E, Hökfelt T, Kehr J.
    CNS Drugs; 2006 Oct 29; 20(8):633-54. PubMed ID: 16863269
    [Abstract] [Full Text] [Related]

  • 20. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase.
    Sulser F, Gillespie DD, Mishra R, Manier DH.
    Ann N Y Acad Sci; 1984 Oct 29; 430():91-101. PubMed ID: 6331266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.